| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0008 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.002 |